Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

When you think of Carla Hall, delicious food, a friendly personality and distinctive eyewear may come to mind. But Hall, of Food Network, “The Chew” and “Top Chef” fame, is adding another role to her ...

GSK (GSK) announced that Japan’s Ministry of Health, Labour and Welfare, MHLW, has approved a regulatory application to extend the indication of Arexvy for the prevention of RSV disease to include ...

Japan’s MHLW grants expanded indication approval to GSK’s RSV vaccine, Arexvy for adults aged 50-59 at increased risk of severe RSV disease: London, UK Saturday, November 23, ...

(Alliance News) - GSK PLC said on Friday that Japan's Ministry of Health, Labour & Welfare has approved the expansion of its Arexvy respiratory syncytial virus vaccine to include adults aged 50 to 59 ...

Arexvy, which from September 2023 had been approved in Japan for adults 60 and over for the prevention of RSV disease, can ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

(RTTNews) - GSK plc (GSK, GSK.L) announced that Japan's Ministry of Health, Labour and Welfare has approved a regulatory application to extend the indication of Arexvy for the prevention of RSV ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, ...

Thankfully, there are currently two RSV vaccines approved by the Food and Drug Administration to help people protect against the virus: Arexvy by GlaxoSmithKline and Abrysvo by Pfizer. The Centers ...

According to the analyst, while forecasts for long-acting HIV injectables, Ojjaara in myelofibrosis, and future pipeline projects remain optimistic, potential headwinds for Arexvy & Shingrix, as well ...